Regulation of psychotropic fixed dose combination drugs in India: a retrospective longitudinal study (Regulation of psychotropic FDCs in India)

14/02/2022
12/04/2022
EU PAS number:
EUPAS45738
Study
Ongoing
Study type

Study type

Non-interventional study

Scope of the study

Drug utilisation
Population studied

Age groups

  • Preterm newborn infants (0 – 27 days)
  • Term newborn infants (0 – 27 days)
  • Infants and toddlers (28 days – 23 months)
  • Children (2 to < 12 years)
  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

0
Study design details

Main study objective

The study aims to assess the impact of the efforts by the Indian government to regulate psychotropic fixed dose combination (FDC) drug sales.

Data analysis plan

Descriptive statistics will be obtained to characterize sales trends over time. Where possible, interrupted time series analysis will be used to assess for changes in sales trends, for drugs banned by the Indian government.